WEPOX 4000 IU INJECTION

Wepox 4000IU injections contain active components like Recombinant human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medication is used to treat anemia that is due to chronic kidney diseases (CKD), as well as chemotherapy for cancer or HIV treatment with zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of blood loss because of planned surgery and other surgical procedures.
Wepox 4000IU injections are not recommended for patients who have hypersensitivity towards it or its constituents, uncontrolled hypertension, active thrombotic microangiopathy (TMA) purified red cell aplasia (PRCA), and seizures that are uncontrolled, and pregnancy or lactation. Also, it should be used with caution in patients with a background of bleeding clots, heart disease, kidney disease, stroke, thalassemia, liver diseases, sickle-cell anemia, myelodysplastic disorder, leukemia, or cancer. It is not recommended to use for children younger than 18 years old when the benefits outweigh the risks. Older adults taking this medication must be monitored closely for any adverse effects. Before you begin this treatment, you must speak with your doctor about the risks and advantages associated with Wepox 4000IU injections .